Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies.
- 2023-12-09
- Meta-Analysis
- JNCI cancer spectrum 8(1)
- M Diana van Die
- Kerry M Bone
- Kala Visvanathan
- Cecile Kyrø
- Dagfinn Aune
- Carolyn Ee
- Channing J Paller
- PubMed: 38070485
- DOI: 10.1093/jncics/pkad104
- High evidence
- Clinical
particularly among postmenopausal (HR = 0.72, 95% CI = 0.55 to 0.94) and estrogen receptor-positive survivors (HR = 0.82, 95% CI = 0.70 to 0.97)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 60 mg/day (greatest risk reduction for recurrence)